U.S. flag

An official website of the United States government

NM_002968.3(SALL1):c.2050C>T (p.Gln684Ter) AND Townes-Brocks syndrome 1

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Oct 8, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001029950.5

Allele description [Variation Report for NM_002968.3(SALL1):c.2050C>T (p.Gln684Ter)]

NM_002968.3(SALL1):c.2050C>T (p.Gln684Ter)

Gene:
SALL1:spalt like transcription factor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q12.1
Genomic location:
Preferred name:
NM_002968.3(SALL1):c.2050C>T (p.Gln684Ter)
HGVS:
  • NC_000016.10:g.51140172G>A
  • NG_007990.1:g.16101C>T
  • NM_001127892.2:c.1759C>T
  • NM_002968.3:c.2050C>TMANE SELECT
  • NP_001121364.1:p.Gln587Ter
  • NP_002959.2:p.Gln684Ter
  • LRG_674t1:c.2050C>T
  • LRG_674:g.16101C>T
  • NC_000016.9:g.51174083G>A
  • NM_002968.2:c.2050C>T
Protein change:
Q587*
Links:
dbSNP: rs1597229404
NCBI 1000 Genomes Browser:
rs1597229404
Molecular consequence:
  • NM_001127892.2:c.1759C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_002968.3:c.2050C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Townes-Brocks syndrome 1 (TBS1)
Synonyms:
DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES; Renal-ear-anal-radial syndrome; Anus, imperforate, with hand, foot and ear anomalies; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0054581; MedGen: C4551481; Orphanet: 857; OMIM: 107480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001192748Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
no assertion criteria provided
Likely pathogenic
(Jun 28, 2019)
germlineclinical testing

SCV001529266Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 7, 2018)
paternalclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005086043Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 8, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedpaternalyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

SALL1-Related Townes-Brocks Syndrome..

Graziano C, Olivucci G.

2007 Jan 24 [updated 2024 Aug 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301618

A Genetics-First Approach Revealed Monogenic Disorders in Patients With ARM and VACTERL Anomalies.

van de Putte R, Dworschak GC, Brosens E, Reutter HM, Marcelis CLM, Acuna-Hidalgo R, Kurtas NE, Steehouwer M, Dunwoodie SL, Schmiedeke E, Märzheuser S, Schwarzer N, Brooks AS, de Klein A, Sloots CEJ, Tibboel D, Brisighelli G, Morandi A, Bedeschi MF, Bates MD, Levitt MA, Peña A, et al.

Front Pediatr. 2020;8:310. doi: 10.3389/fped.2020.00310.

PubMed [citation]
PMID:
32656166
PMCID:
PMC7324789
See all PubMed Citations (3)

Details of each submission

From Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare, SCV001192748.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV001529266.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1paternalyesnot providednot providednot providednot providednot providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV005086043.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Townes-Brocks syndrome (MIM#107480) and Townes-Brocks branchiootorenal-like syndrome (MIM#107480). NMD escape has been demonstrated for a single PTC in the 5' end of exon 2, where dominant negative or gain of function is a suggested mechanism (PMID: 20301618). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Pathogenic variants within the 5' end exon 2 hot spot region appear to be associated with a more severe outcome than pathogenic variants towards the 3' end in exon 2 (PMID: 20301618). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic in a heterozygous individual with Townes-Brocks syndrome (PMID: 32656166). This variant has also been reported as likely pathogenic and VUS in ClinVar. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status confirmed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024